top of page

Dental Bone Graft Substitutes Market Growth and Industry Forecast

  • Writer: marketinsightspro8
    marketinsightspro8
  • 2 hours ago
  • 3 min read

The global Dental Bone Graft Substitutes Market was valued at USD 328.14 million in 2025 and is expected to grow from USD 350.25 million in 2026 to USD 612.03 million by 2034, exhibiting a CAGR of 7.23% during the forecast period (2026-2034). Increasing prevalence of dental disorders, rising adoption of dental implants, and continuous advancements in regenerative medicine are driving market expansion.

Growing Demand for Dental Implant Procedures Supporting Market Expansion

Dental bone graft substitutes are increasingly being used to regenerate lost bone tissue and improve the success rate of dental implant procedures. Rising awareness regarding oral health and growing demand for cosmetic dentistry are creating favorable opportunities for market growth. Furthermore, the development of advanced allografts, xenografts, and synthetic bone graft materials is strengthening product adoption worldwide.

Latest Trend: Emergence of 3D-Printed Synthetic Bone Grafts

One of the major trends shaping the Dental Bone Graft Substitutes Market is the increasing use of 3D-printed regenerative bone graft products. Customized bone grafts designed through additive manufacturing provide better compatibility and improved healing outcomes. Regulatory approvals and technological innovations are expected to further accelerate market development.

Market Drivers

Increasing Incidence of Dental Diseases

The growing burden of periodontal diseases and tooth loss is increasing the demand for dental restoration procedures. Bone graft substitutes have become essential for alveolar ridge preservation and implant placement, thereby contributing significantly to market growth.

Introduction of Advanced Products

Manufacturers are focusing on launching technologically advanced products to improve clinical outcomes. Increasing research activities and favorable regulatory approvals are further supporting the adoption of next-generation bone graft substitutes.

Segmentation Analysis

By Product Type

  • Allograft

  • Synthetic Bone Graft Substitutes

  • Demineralized Bone Matrix

  • Xenograft

Among these segments, the Demineralized Bone Matrix (DBM) segment accounted for the leading market share owing to its superior osteoinductive properties and broad clinical applications.

By Form

  • Granules

  • Putty

  • Others

By End User

  • Solo Practices

  • DSO/Group Practices

  • Others

Regional Insights

North America Dominated the Global Market

North America held the largest share of 47.93% in 2025 and generated revenue of USD 156.88 million. Rising numbers of dental implant procedures, increasing prevalence of bone injuries, and strong presence of leading market players are supporting regional growth.

Europe Maintained a Strong Position

Europe accounted for 26.02% of the market and generated USD 85.77 million in revenue during 2025. High investments in research and development and increasing strategic acquisitions are driving market expansion.

Asia Pacific Expected to Witness Significant Growth

Asia Pacific generated USD 64.26 million in 2025 and represented 19.72% of the global market. Growing geriatric population, increasing prevalence of dental disorders, and expanding healthcare infrastructure are contributing to growth across China, Japan, and India.

Competitive Landscape

Leading companies are emphasizing acquisitions, collaborations, and product innovations to strengthen their market positions. Key players operating in the market include:

  • ZimVie Inc.

  • Medtronic

  • Geistlich Pharma AG

  • Zimmer Biomet

  • Biocomposites

  • RevBio, Inc.

Industry Developments

  • In February 2024, Geistlich Pharma AG introduced Vallos Granules, a demineralized allograft for dental applications.

  • In June 2023, RevBio, Inc. received a USD 2 million Phase II SBIR grant from the National Institutes of Health to advance its dental adhesive bone scaffold product.

  • In June 2023, Biocomposites acquired Artoss to strengthen its bone graft substitute portfolio.

  • In December 2022, Desktop Metal received FDA approval for its CMFlex 3D-printed regenerative bone graft product.

Related Reports

Frequently Asked Questions (FAQs)

How big is the Dental Bone Graft Substitutes Market?

The market was valued at USD 328.14 million in 2025 and is projected to reach USD 612.03 million by 2034.

What is the growth rate of the market?

The market is anticipated to exhibit a CAGR of 7.23% during 2026-2034.

Which region dominates the market?

North America dominated the global market with a 47.93% share in 2025.

Which product segment held the largest share?

The Demineralized Bone Matrix segment emerged as the leading product category.

Request a Free Sample Report

The Dental Bone Graft Substitutes Market is expected to witness substantial growth over the coming years, supported by technological advancements, rising dental implant procedures, and increasing awareness regarding oral healthcare. Strategic partnerships and innovative product launches are likely to create new opportunities for stakeholders throughout the forecast period.

 
 
 

Recent Posts

See All

Comments


bottom of page